This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_BREAST_EXALLC for full statistics.
Carcinoma in situ of breast
DOID EFO MESH Endpoint Browser
CD2_INSITU_BREAST
breast ductal carcinoma in situ: A carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule
Sex
only females
239906
Check conditions
not C3_BREAST
220530
Check pre-conditions, main-only, mode, registry filters
Hospital Discharge: ICD-10
D05
Cause of death: ICD-10
D05
Cancer registry: Topography ICD-O-3
C50
Cancer registry: Morphology ICD-O-3
ANY
Cancer registry: Behaviour codes
2
3 out of 7 registries used, show all original rules.
-
Check minimum number of events None
-
Remove individuals based on genotype QC
241
CD2_INSITU_BREAST
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF9
Parent code in ICD-10
D00-D09
Name in latin
Carcinoma in situ vulvae
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of breast
based on the number of shared cases.
Broader endpoints:
- Carcinoma in situ of breast (controls excluding all cancers)
- In situ neoplasms
- In situ neoplasms (controls excluding all cancers)
- Neoplasms
- Any operation in hilmo
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 241 | 241 | - |
| Unadjusted prevalence (%) | 0.06 | 0.10 | - |
| Mean age at first event (years) | 60.74 | 60.74 | - |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: CD2_INSITU_BREAST – Carcinoma in situ of breast
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Carcinoma in situ of breast
↥Endpoint not on priority list, no data to show.